Losartan Potassium and Ezetimibe prescription drug bottles
CPSC Recall #19-194 — August 29, 2019
Product
Losartan Potassium and Ezetimibe prescription drug bottles
Description
This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers. The recalled bottles have “Sandoz,” the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels. The recall includes the following: Recalled Prescription DrugsNDC NumbersLot NumbersExpiration DateEzetimibe 10mg Tablets0781-5690-31JE4491Aug-202030 count bottle JE4492Aug-2020 JE4493Aug-2020 JE4495Aug-2020 JG0308Sep-2020 JG0310Sep-2020 JG0311Sep-2020 JG0312Sep-2020 JG5061Sep-2020 JG5063Sep-2020 JK8921Oct-2020 JK8922Oct-2020 JK8923Oct-2020 JK8924Oct-2020 JL5535Oct-2020 JM2253Oct-2020 JM2254Oct-2020 JM2255Oct-2020 JM2257Oct-2020 JM2258Oct-2020 JM2259Oct-2020 JM5986Oct-2020 JM5987Oct-2020Ezetimibe 10mg Tablets0781-5690-92JE4481Aug-202090 count bottle JG0249Sep-2020 JK8989Oct-2020 JN0764Jan-2021Losartan Potassium 50mg Tablets0781-5701-31HV9471Feb-202030 count bottle
Hazard
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
Incidents / Injuries
None Reported
Remedy
Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.
Units Affected
About 636,000
Sold At
Clinics and pharmacies nationwide as a prescribed medicine from July 2018 through August 2019. The container was included in the price of the medication, which varied based on quantities prescribed, health insurance terms and other factors.
Manufactured In
Slovenia